Lineage Cell Therapeutics (LCTX) Proxy filing summary

Voting matters and shareholder proposals

• Shareholders will vote to elect seven directors to serve until the 2027 annual meeting and until successors are elected and qualified.

• Proposal to ratify Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory vote on the compensation paid to named executive officers is included.

• Board recommends voting for all director nominees and for proposals 2 and 3.

• Other business may be transacted as properly brought before the meeting or any adjournment.

Board of directors and corporate governance

• Seven director nominees are listed: Michael H. Mulroy, Dipti Amin, Deborah Andrews, Neal C. Bradsher, Brian M. Culley, Anula Jayasuriya, and Angus C. Russell.

Executive compensation and say-on-pay

• Advisory vote will be held regarding the compensation of named executive officers.